4MRO
Human GKRP bound to AMG-5980 and S6P
4MRO の概要
エントリーDOI | 10.2210/pdb4mro/pdb |
関連するPDBエントリー | 4MQU |
分子名称 | Glucokinase regulatory protein, 2-(4-{4-[(6-aminopyridin-3-yl)sulfonyl]piperazin-1-yl}phenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol, D-SORBITOL-6-PHOSPHATE, ... (7 entities in total) |
機能のキーワード | sis domains, regulatory protein, glucokinase, phospho-fructose, transferase inhibitor |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Nucleus (By similarity): Q14397 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 145403.00 |
構造登録者 | St Jean, D.J.,Ashton, K.S.,Bartberger, M.D.,Chen, J.,Chmait, S.,Cupples, R.,Galbreath, E.,Helmering, J.,Jordan, S.R.,Liu, L.,Kunz, K.,Michelsen, K.,Nishimura, N.,Pennington, L.D.,Poon, S.F.,Sivits, G.,Stec, M.M.,Tamayo, N.,Van, G.,Yang, K.,Norman, M.H.,Fotsch, C.,LLoyd, D.J.,Hale, C. (登録日: 2013-09-17, 公開日: 2014-05-07, 最終更新日: 2024-04-03) |
主引用文献 | St Jean, D.J.,Ashton, K.S.,Bartberger, M.D.,Chen, J.,Chmait, S.,Cupples, R.,Galbreath, E.,Helmering, J.,Hong, F.T.,Jordan, S.R.,Liu, L.,Kunz, R.K.,Michelsen, K.,Nishimura, N.,Pennington, L.D.,Poon, S.F.,Reid, D.,Sivits, G.,Stec, M.M.,Tadesse, S.,Tamayo, N.,Van, G.,Yang, K.C.,Zhang, J.,Norman, M.H.,Fotsch, C.,Lloyd, D.J.,Hale, C. Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles. J.Med.Chem., 57:325-338, 2014 Cited by PubMed Abstract: In the previous report , we described the discovery and optimization of novel small molecule disruptors of the GK-GKRP interaction culminating in the identification of 1 (AMG-1694). Although this analogue possessed excellent in vitro potency and was a useful tool compound in initial proof-of-concept experiments, high metabolic turnover limited its advancement. Guided by a combination of metabolite identification and structure-based design, we have successfully discovered a potent and metabolically stable GK-GKRP disruptor (27, AMG-3969). When administered to db/db mice, this compound demonstrated a robust pharmacodynamic response (GK translocation) as well as statistically significant dose-dependent reductions in fed blood glucose levels. PubMed: 24405213DOI: 10.1021/jm4016747 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.2 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード